← FDA Drug Approvals (Drugs@FDA)
BEYFORTUS
BLA · Biologics License Application · Sponsor: ASTRAZENECA AB · Approved 2023-07-17
Drug application
- FDA Application #
BLA761328- Application type
- Biologics License Application
- Brand name
- BEYFORTUS
- Generic name
- NIRSEVIMAB
- Active ingredients
- NIRSEVIMAB-ALIP
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- ASTRAZENECA AB
- Manufacturer
- Sanofi Vaccines US Inc.
- First approval
- 2023-07-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown